CMAC’s vision is to revolutionise the way pharmaceuticals and high value products are made. The approaches developed and adopted within CMAC have been developed through close collaboration with industry and the support of its Tier 1 partners, which includes GlaxoSmithKline, AstraZeneca, Bayer, Lilly, Novartis, Pfizer, Roche and Takeda. Established in 2011, the CMAC has a £150m funding portfolio and currently comprises more than 130 staff and researchers, including academics, post docs, and more than 30 PhD students, as well as an experienced support team.
MIT-CMAC International Symposium on Continuous Manufacturing of Pharmaceuticals
This symposium brings together pharmaceutical industrialists, regulators, policy makers and academics to look at how the community can grow medicines manufacturing in the UK and accelerate the adoption of advanced manufacturing and digital technologies. To achieve this we need an integrated approach, harnessing the combined efforts of the stakeholders to lead the transformation that will enhance quality, cost and sustainability of medicines manufacture, ultimately for the benefit of patients..... more
CMAC - Hub Coding Technician
CMAC are seeking a Hub Coding Technician to adapt advanced digital technologies for partner needs by providing technical development expertise, and to develop the digital tools and workflows..... more
Automated Synthesis Forum
At TIC, University of Strathclyde.... more
MIT-CMAC International Symposium on Continuous Manufacturing of Pharmaceuticals
An Integrated Ecosystem for Transforming Medicines Manufacturing
Registration OPEN
18th February 2021, 12.30-17.00 GMT
This symposium brings together pharmaceutical industrialists, regulators, policy makers and academics to look at how the community can grow medicines manufacturing in the UK and accelerate the adoption of advanced manufacturing and digital technologies. To achieve this we need an integrated approach, harnessing the combined efforts of the stakeholders to lead the transformation that will enhance quality, cost and sustainability of medicines manufacture, ultimately for the benefit of patients. .... more
Laminar and UK/IRE Distributor Analytik Join CMAC Future Manufacturing Research Hub
Continuous flow chemical reactor manufacturer Laminar Co Ltd (Jungwon-gu, Republic of Korea), represented in the UK and Ireland by Analytik Ltd (Cambridge, UK), have joined the CMAC Future Manufacturing Research Hub as tier 2 members from October 2020..... more
Launch of CMAC - Huxley Bertram Partnership to Support Compaction Simulation Research and Services
CMAC are pleased to announce that following the recent establishment of our new Compaction Simulation Pilot Test Facility, we can now offer Compaction Simulation Research Services through our National Facility Team. This is supported by a new partnership between Huxley Bertram and the CMAC Future Manufacturing Research Hub at the University of Strathclyde (Glasgow, UK). .... more